Pancreatic Cancer Research

ResearcherKobe UniversityNo recent work listed

Sachiyo Shirakawa

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4608-4863; OpenAlex author ID A5077246645. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper

Papers 10

  1. Clinicopathological variables and risk factors for lung recurrence after resection of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.asjsur.2022.03.043↗
  2. Abbreviated Gadoxetic Acid-Enhanced MRI for the Detection of Liver Metastases in Patients With Potentially Resectable Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1002/jmri.28059↗
  3. [A Patient with Ascending Jejunal Mesentery Metastasis of Pancreatic Cancer after a Subtotal Stomach-Preserving Pancreaticoduodenectomy]. Co-author PMID 35045476↗
  4. Response to: "timing of administration of indocyanine green for fluorescence-guided surgery in pancreatic cancer: response to Shirakawa et al." Co-author DOI 10.1186/s12893-020-00815-7↗
  5. A prospective single-center protocol for using near-infrared fluorescence imaging with indocyanine green during staging laparoscopy to detect small metastasis … Co-author DOI 10.1186/s12893-019-0635-0↗
  6. Pathological and Radiological Splenic Vein Involvement are Predictors of Poor Prognosis and Early Liver Metastasis After Surgery in Patients with Pancreatic Ad… Co-author DOI 10.1245/s10434-017-6274-8↗
  7. [A Case of Pancreatic Cancer with Multiple Lymph Node Swelling Caused by Sarcoidosis]. Co-author PMID 29394809↗
  8. Postoperative Serum Albumin Level is a Marker of Incomplete Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1245/s10434-014-4280-7↗
  9. 18-Fluorodeoxyglucose positron emission tomography does not aid in diagnosis of pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.cgh.2012.12.033↗
  10. [A case of interstitial lung disease associated with gemcitabine treatment in a patient with locally advanced pancreatic cancer following proton beam radiother… Co-author PMID 23268009↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Takumi Fukumoto · 10 shared papers, 2012–2023 · strength 0.94
  2. Hirochika Toyama · 8 shared papers, 2012–2023 · strength 0.84
  3. Sadaki Asari · 7 shared papers, 2012–2023 · strength 0.49
  4. Jun Ishida · 3 shared papers, 2015–2023 · strength 0.30
  5. Hiroaki Yanagimoto · 2 shared papers, 2021–2023 · strength 0.26
  6. Yu Asakura · 2 shared papers, 2021–2023 · strength 0.26
  7. Yuta Ogura · 2 shared papers, 2021–2023 · strength 0.26
  8. Ippei Matsumoto · 4 shared papers, 2012–2023 · strength 0.25
  9. Keitaro Sofue · 2 shared papers, 2018–2022 · strength 0.22
  10. Tadahiro Goto · 4 shared papers, 2012–2017 · strength 0.16
  11. Yonson Ku · 4 shared papers, 2012–2017 · strength 0.16
  12. Takamichi Murakami · 1 shared paper, 2022 · strength 0.15
  13. Takeru Yamaguchi · 1 shared paper, 2022 · strength 0.15
  14. Motofumi Tanaka · 2 shared papers, 2017–2018 · strength 0.13
  15. Takuya Mizumoto · 2 shared papers, 2017–2018 · strength 0.13
  16. Yoshihide Nanno · 2 shared papers, 2017–2018 · strength 0.13
  17. Takashi Shimizu · 1 shared paper, 2021 · strength 0.11
  18. Masaki Tanaka · 2 shared papers, 2012–2015 · strength 0.07
  19. Mototsugu Shimokawa · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.